Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$190.52 - $236.72 $192,044 - $238,613
1,008 New
1,008 $233,000
Q4 2023

May 30, 2024

BUY
$222.59 - $267.94 $192,762 - $232,036
866 New
866 $224,000
Q3 2021

Nov 15, 2021

SELL
$282.99 - $369.05 $318,646 - $415,550
-1,126 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $9,842 - $15,758
38 Added 3.49%
1,126 $384,000
Q1 2021

May 14, 2021

BUY
$242.95 - $284.63 $6,802 - $7,969
28 Added 2.64%
1,088 $304,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $24,098 - $36,274
-102 Reduced 8.78%
1,060 $260,000
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $7,678 - $8,865
29 Added 2.56%
1,162 $330,000
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $28,452 - $37,680
-110 Reduced 8.85%
1,133 $303,000
Q1 2020

May 14, 2020

BUY
$268.85 - $341.04 $93,022 - $117,999
346 Added 38.57%
1,243 $393,000
Q4 2019

Feb 12, 2020

BUY
$220.06 - $304.07 $197,393 - $272,750
897 New
897 $266,000
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $195,606 - $215,614
-892 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$216.71 - $338.96 $31,639 - $49,488
-146 Reduced 14.07%
892 $211,000
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $3,620 - $4,585
13 Added 1.27%
1,038 $312,000
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $114,468 - $149,693
-390 Reduced 27.56%
1,025 $362,000
Q2 2018

Aug 15, 2018

BUY
$257.52 - $306.91 $22,146 - $26,394
86 Added 6.47%
1,415 $411,000
Q1 2018

May 14, 2018

SELL
$260.13 - $367.91 $53,846 - $76,157
-207 Reduced 13.48%
1,329 $364,000
Q4 2017

Feb 15, 2018

BUY
$307.64 - $344.58 $472,535 - $529,274
1,536
1,536 $489,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Lake Street Advisors Group, LLC Portfolio

Follow Lake Street Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lake Street Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lake Street Advisors Group, LLC with notifications on news.